<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02903615</url>
  </required_header>
  <id_info>
    <org_study_id>16/053</org_study_id>
    <nct_id>NCT02903615</nct_id>
  </id_info>
  <brief_title>Optimising Health in Type 1 Diabetes</brief_title>
  <official_title>The Optimal Diet for Optimising Health in Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Garvan Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Garvan Institute of Medical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 1 diabetes is an autoimmune condition where circulating immune cells destroy the
      beta-cells in the pancreas that make insulin, resulting in a degree of insulin deficiency,
      whereby blood glucose levels rise and diabetes develops. When there is severe insulin
      deficiency, life-threatening ketoacidosis can develop. Treatment is lifelong insulin
      replacement therapy; dietary intervention is a also cornerstone of glucose management.

      The Optimise Diet is a multi-pronged diet based on &quot;best health&quot; principles: to minimise
      blood glucose rises after eating, reduce the immune cells involved in destruction of the
      insulin-secreting beta-cells, and improve the gut microbiome and systemic inflammation. In
      this study, its effects will be compared to the Standard Diabetes Diet that is currently
      recommended in Australia and internationally.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The rationale for this study is to determine whether a diet based on recent scientific
      advances in diet-induced inflammation, will improve diabetes care in people with type 1
      diabetes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose control</measure>
    <time_frame>3 months</time_frame>
    <description>HbA1c</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>3 months</time_frame>
    <description>Circulating immune cells numbers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut microbiome</measure>
    <time_frame>3 months</time_frame>
    <description>Gut flora subtypes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-peptide</measure>
    <time_frame>3 months</time_frame>
    <description>Urinary excretion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postprandial glucose excursion</measure>
    <time_frame>3 months</time_frame>
    <description>postprandial glucose excursion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow-up of glycemic control and insulin secretion</measure>
    <time_frame>12 and 24 months</time_frame>
    <description>HbA1c, urinary C-peptide</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Novel type 1 diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental diet to be examined: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard therapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard dietary therapy, as promulgated by Australian standards</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Novel diet</intervention_name>
    <description>Novel diet to optimise glucose levels and minimise systemic inflammation: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus.</description>
    <arm_group_label>Novel type 1 diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard diet</intervention_name>
    <description>Standard diabetes diet recommendations</description>
    <arm_group_label>Standard therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 1 diabetes

        Exclusion Criteria:

          -  Women lactating, pregnant or of childbearing potential who are not willing to avoid
             becoming pregnant during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine Samaras, MD PhD FRACP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Garvan Institute of Medical Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katherine Samaras</last_name>
    <email>k.samaras@garvan.org.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>professor Katherine Samaras</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Samaras, MBBS FRACP PhD</last_name>
      <email>k.samaras@garvan.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Garvan Institute to Medical Research</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katherine Samaras</last_name>
      <email>k.samaras@garvan.org.au</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2016</study_first_submitted>
  <study_first_submitted_qc>September 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2016</study_first_posted>
  <last_update_submitted>March 21, 2018</last_update_submitted>
  <last_update_submitted_qc>March 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Garvan Institute of Medical Research</investigator_affiliation>
    <investigator_full_name>Professor Katherine Samaras</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>glucose</keyword>
  <keyword>inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

